Lataa...
Clinical Challenges with Talimogene Laherparepvec: Cured Lymph Nodes Masquerading as Active Melanoma
Talimogene laherparepvec is a novel, genetically engineered, oncolytic herpes virus approved for local treatment of unresectable cutaneous, subcutaneous, and nodal lesions in patients with melanoma recurrent after initial surgery. It is administered as an intralesional injection. However, if the les...
Tallennettuna:
| Julkaisussa: | Case Rep Oncol Med |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Hindawi
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6431461/ https://ncbi.nlm.nih.gov/pubmed/30963012 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/4683531 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|